YOLFTbeta
Yuhan Corp.

Yuhan Corp.

000100 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

80,100.00KRW+300.00 (+0.38%)

Price History

Full chart

Market Stats

Previous Close79,800.00
Open79,100.00
Day Range78,500.00 – 81,300.00
52-Week Range65,000.00 – 128,514.59
Volume149.91K
Market Cap5.36T
P/E (TTM)0.00
Forward P/E14.88
Dividend Yield0.82%
Beta0.42
50-Day Avg78,212.00
200-Day Avg90,788.00

About

Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Wook-Je Cho
  • Employees2.08K
  • Headquarters74, Noryangjin-ro, Seoul, South Korea, Korea
  • Websitehttps://www.yuhan.co.kr

Leadership

  • Mr. Wook-Je ChoPresident, CEO & Executive Director · b. 1955
  • Mr. Yeul-Hong KimPresident, R&D Director & Executive Director · b. 1959
  • Mr. Byung-Man LeeVP, Head of the Mngt. HQ. & Internal Accounting Manager · b. 1958
  • Ms. Eunhee ParkMD & Director of Legal Affairs · b. 1971
  • Mr. Joo-Yong ChungMD & Head of Marketing Department · b. 1967
  • Mr. Jae-Kyo KimVP & Head of the Pharmaceutical Business Division · b. 1968
  • Mr. Sung-Soo KimMD & Head of the Lifestyle Health Business Division · b. 1964
  • Mr. Jun-Hwan KimMD & Head of Biopharmaceutical Division · b. 1975
  • Mr. Min Chul ChoMD & ESG Management Director · b. 1965
  • Mr. Chanhwan ParkMD & Head of Management Department · b. 1972

Financials

Income Statement

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue223.50B261.74B290.72B309.65B345.53B401.79B422.48B493.29B611.19B646.77B663.57B679.23B776.46B943.61B1.02T1.13T1.32T1.46T1.52T1.48T1.62T1.69T1.78T1.86T2.07T2.19T
Growth (%)-+17.11%+11.07%+6.51%+11.59%+16.28%+5.15%+16.76%+23.90%+5.82%+2.60%+2.36%+14.31%+21.53%+7.83%+10.93%+17.02%+10.71%+3.87%-2.53%+9.42%+4.19%+5.22%+4.68%+11.23%+5.75%
Cost of Revenue115.21B130.79B152.15B156.78B175.07B177.36B194.70B230.80B299.79B334.68B368.42B410.12B515.14B632.60B677.41B789.14B931.36B1.04T1.11T1.05T1.06T1.16T1.26T1.29T1.38T1.46T
Gross Profit-------------292.92B314.52B339.59B389.44B424.62B413.79B430.85B558.42B524.65B518.20B565.86B689.39B729.92B
Gross Margin-------------31.04%30.91%30.09%29.49%29.04%27.24%29.10%34.47%31.08%29.18%30.44%33.34%33.38%
Operating Expense-------------231.08B240.13B253.75B291.65B335.91B363.67B418.32B474.17B476.05B482.17B508.83B634.51B625.54B
Operating Income35.49B41.78B45.68B52.51B57.45B72.73B66.13B71.64B82.98B86.35B82.64B52.73B34.60B61.84B74.39B85.84B97.79B88.71B50.13B12.54B84.26B48.60B36.03B57.03B54.88B104.37B
Operating Margin15.88%15.96%15.71%16.96%16.63%18.10%15.65%14.52%13.58%13.35%12.45%7.76%4.46%6.55%7.31%7.60%7.40%6.07%3.30%0.85%5.20%2.88%2.03%3.07%2.65%4.77%
EBITDA-----------------201.73B152.06B116.68B302.39B181.68B141.41B185.52B139.20B307.23B
EBITDA Margin-----------------13.80%10.01%7.88%18.67%10.76%7.96%9.98%6.73%14.05%
Net Income32.98B38.94B44.03B51.37B50.91B61.15B65.23B89.76B122.64B118.97B125.20B92.40B79.25B84.86B89.12B126.05B161.25B109.03B57.48B40.01B192.76B102.58B95.14B136.20B70.69B194.08B
Net Income Margin14.75%14.88%15.14%16.59%14.73%15.22%15.44%18.20%20.07%18.39%18.87%13.60%10.21%8.99%8.76%11.17%12.21%7.46%3.78%2.70%11.90%6.08%5.36%7.33%3.42%8.88%
R&D----------21.41B50.39B47.73B56.31B58.01B39.02B52.67B71.43B74.07B96.90B142.63B106.68B107.10B119.92B224.76B219.71B
R&D as % of Total Revenue----------3.23%7.42%6.15%5.97%5.70%3.46%3.99%4.89%4.88%6.55%8.81%6.32%6.03%6.45%10.87%10.05%
Interest Expense0000000000000000003.67B3.10B2.71B2.94B3.47B6.30B14.73B15.40B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.24%0.21%0.17%0.17%0.20%0.34%0.71%0.70%

Balance Sheet

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets556.14B583.76B631.04B659.58B764.90B898.67B941.40B997.19B1.04T1.13T1.26T1.31T1.40T1.51T1.62T1.88T2.05T2.09T2.17T2.12T2.39T2.46T2.47T2.81T2.94T3.22T
Total Liabilities232.55B214.31B223.10B197.55B245.88B305.81B268.99B240.74B176.29B167.09B182.79B197.34B214.87B285.72B340.11B516.39B549.39B488.35B522.08B467.21B547.02B527.92B464.92B711.65B791.38B858.64B
Total Equity323.58B369.44B407.93B462.04B519.03B592.86B672.40B756.45B862.60B967.71B1.07T1.12T1.19T1.23T1.28T1.36T1.50T1.60T1.64T1.65T1.84T1.93T1.99T2.05T2.10T2.31T
Cash27.54B38.15B47.95B69.35B74.11B60.96B81.18B105.58B146.36B250.46B150.18B178.95B195.00B269.95B155.68B221.81B244.85B256.61B241.30B274.22B353.49B253.59B293.04B299.26B306.48B348.56B

Cash Flow

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow31.24B52.85B25.73B33.02B35.56B40.99B36.10B97.85B123.12B134.38B149.59B72.38B72.38B79.78B94.39B126.23B74.14B126.13B93.45B65.99B28.83B99.00B99.53B127.75B54.60B106.23B
Investing Cash Flow825.53M--23.82B-------29.50B--10.58B-192.25B-117.79B-77.14B-42.24B-58.15B31.60B57.59B-167.14B15.62B---
Financing Cash Flow----6.46B26.96B-------5.71B-16.39B57.39B23.30B-68.17B-51.38B-67.01B11.69B-36.53B-65.54B---
Capital Expenditure12.97B9.97B8.85B12.41B53.45B82.05B31.59B17.30B21.25B8.00B7.98B10.93B23.35B55.76B35.84B81.26B84.63B56.77B46.00B42.76B51.45B46.15B65.80B72.41B133.92B144.74B
Free Cash Flow-----------------66.21B44.86B19.25B-62.35B17.13B5.15B55.35B-79.31B-38.51B
Dividends Paid5.17B4.29B6.46B6.76B7.01B7.61B9.26B8.74B9.21B9.66B10.12B10.54B13.21B13.20B15.63B18.04B20.55B20.75B21.94B22.91B23.78B24.94B26.08B27.27B32.15B37.48B
FCF to OCF-----------------52.50%48.00%29.17%-216.25%17.30%5.18%43.32%-145.26%-36.25%
Dividend Paid to FCF-----------------31.33%48.91%119.02%-38.14%145.63%506.34%49.27%-40.53%-97.33%

Earnings

Report DateNov 11, 2004May 5, 2005Jul 27, 2005Nov 2, 2005Apr 25, 2006Jul 25, 2006Nov 8, 2006Feb 1, 2007Apr 24, 2007Jul 24, 2007Oct 17, 2007Jan 21, 2008Apr 28, 2008Jul 24, 2008Dec 15, 2008May 27, 2009Oct 6, 2009Jan 26, 2010May 14, 2010Aug 13, 2010Oct 31, 2010Apr 28, 2011Aug 12, 2011Nov 10, 2011Feb 29, 2012May 14, 2012Jul 27, 2012Nov 8, 2012Feb 27, 2013May 13, 2013Jul 26, 2013Nov 7, 2013Feb 26, 2014Apr 29, 2014Jul 29, 2014Nov 28, 2014Feb 25, 2015Apr 29, 2015Aug 17, 2015Oct 28, 2015Mar 30, 2016Apr 28, 2016Aug 16, 2016Nov 14, 2016Mar 16, 2017Apr 27, 2017Aug 11, 2017Nov 14, 2017Feb 20, 2018Apr 26, 2018Jul 27, 2018Nov 14, 2018Feb 18, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 27, 2020May 15, 2020Aug 14, 2020Nov 16, 2020Feb 24, 2021May 17, 2021Aug 17, 2021Nov 15, 2021Mar 10, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Feb 22, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Feb 6, 2024May 16, 2024Aug 13, 2024Nov 14, 2024Feb 12, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Mar 11, 2026May 15, 2026Aug 14, 2026
EPS Estimate199.06209.49258.42207.62203.45366.46288.70462.50260.15336.97217.87524.791282.78363.67339.00374.98423.87444.82432.11482.78420.36479.35428.01-----------1318.00172.41--233.51-425.192902.50315.67343.35229.243103.23423.74496.872846.97472.09481.21409.78329.26396.91288.44276.55270.45307.11624.11492.96724.26346.93383.02596.74603.00339.16458.24598.80323.54280.16354.87280.59271.18303.89391.94773.23557.89118.52477.70289.45436.49195.93605.68
EPS Actual142.66175.87291.25282.05198.63237.69124.10287.84287.88375.64293.90116.94369.75408.81460.61440.18368.72369.75444.52459.86343.95304.63243.39219.35342.11346.1532.92155.82361.56302.37320.71204.24286.73281.192577.00155.27243.23340.15224.58621.57368.204526.98449.15317.30717.362487.07386.75349.091795.01336.69263.76142.83141.68204.3471.61188.6772.021528.58446.73401.48174.66285.71471.65406.00171.43222.86462.5999.77526.14296.19115.24270.481140.21169.00428.00499.00-154.00118.00617.00348.001532.00372.00950.00
Surprise-28.33%-16.05%12.70%35.85%-2.37%-35.14%-57.01%-37.76%10.66%11.48%34.90%-77.72%-71.18%12.41%35.87%17.39%-13.01%-16.88%2.87%-4.75%-18.18%-36.45%-43.13%-----------95.52%-9.94%---3.82%--13.40%55.97%42.28%-7.59%212.93%-19.86%-8.73%-29.74%-36.95%-28.68%-45.19%-65.14%-56.97%-48.52%-75.17%-31.78%-73.37%397.73%-28.42%-18.56%-75.88%-17.65%23.14%-31.96%-71.57%-34.29%0.95%-83.34%62.62%5.72%-67.53%-3.60%320.46%-44.39%9.20%-35.47%-127.60%-0.44%29.16%20.23%250.98%89.86%56.85%
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours-----------Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketAfter-hours--Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap5.36T
Enterprise Value5.43T
Trailing P/E0.00
Forward P/E14.88
PEG Ratio0.00
Price / Sales2.35
Price / Book2.32
Revenue (TTM)2.28T
Gross Profit (TTM)758.11B
EBITDA202.52B
Profit Margin10.39%
Operating Margin10.48%
Return on Equity9.51%
Return on Assets2.45%
Shares Outstanding73.62M
Shares Float61.76M
Beta0.42
Dividend Yield0.82%
Dividend Rate600.00
Payout Ratio18.74%

Dividends

20261×
600.00Feb 26, 2026
20241×
500.00Dec 27, 2024
20231×
450.00Dec 27, 2023
20221×
380.95Dec 28, 2022
20211×
362.81Dec 29, 2021
20201×
329.08Dec 29, 2020
20191×
329.08Dec 27, 2019
20181×
313.41Dec 27, 2018
20171×
298.49Dec 27, 2017
20161×
180.49Dec 28, 2016
20151×
270.74Dec 29, 2015
20141×
236.89Dec 29, 2014
20131×
203.05Dec 27, 2013
20121×
169.21Dec 27, 2012
20111×
169.21Dec 28, 2011
20101×
128.92Dec 29, 2010
20091×
135.37Dec 29, 2009
20081×
128.92Dec 29, 2008
20071×
122.78Dec 27, 2007
20061×
116.94Dec 27, 2006
20051×
111.38Dec 28, 2005
20041×
106.08Dec 29, 2004
20031×
101.03Dec 29, 2003
20021×
96.22Dec 27, 2002

Stock Splits

  • Dec 27, 20231.05:1
  • Dec 28, 20221.05:1
  • Dec 29, 20211.05:1
  • Dec 29, 20201.05:1
  • Apr 8, 20205:1
  • Dec 27, 20191.05:1
  • Dec 27, 20181.05:1
  • Dec 27, 20171.05:1
  • Dec 28, 20161.05:1
  • Dec 29, 20101.05:1
  • Dec 29, 20091.05:1
  • Dec 29, 20081.05:1
  • Dec 27, 20071.05:1
  • Dec 27, 20061.0499:1
  • Dec 28, 20051.0499:1